Effects of a 6-week semi-supervised exercise training program on physical fitness and mental health in post-COVID-19 healthcare workers: a randomized clinical trial

一项为期6周的半监督式运动训练计划对新冠肺炎后医护人员身体素质和心理健康的影响:一项随机临床试验

阅读:1

Abstract

BACKGROUND: Healthcare workers rank among the groups that are most vulnerable to the SARS-CoV-2 infection. Deterioration in physical fitness and mental health is a common manifestation in the post-COVID-19 person, which require specific and effective treatment. This study aimed to evaluate the effects of a 6-week, semi-supervised exercise intervention on physical fitness and mental health in post-COVID-19 healthcare workers (HCWs). METHODS: Fifty-four HCWs infected with SARS-CoV-2 within 3-4 weeks were randomly assigned to an exercise group or a control group. The exercise group followed a 6-week semi-supervised program with three weekly 60-80-minute sessions. Assessments included handgrip strength, sit-to-stand, push-up, curl-up, cardiorespiratory fitness, flexibility, balance, and mental health. Analyses followed intention-to-treat principles. RESULTS: Compared with those of the control group, the push-up scores (p = 0.003, η(p)(2) = 0.162), curl-up scores (p < 0.001, η(p)(2) = 0.248), and maximum load of the rowing ergometer (p = 0.012, η(p)(2) = 0.121) significantly increased in the exercise group. The depression (p = 0.003) and anxiety (p = 0.023) scores significantly decreased at the end of the intervention in the exercise group, although no significant differences were observed between the groups. No adverse events potentially linked to the intervention were observed. CONCLUSIONS: A six-week semi-supervised exercise training significantly improved functional muscle strength and endurance, and maximum rowing intensity in post-COVID-19 HCWs compared to controls, along with within-group reductions in depression and anxiety. No adverse events were reported. These findings suggest that exercise may be a safe and effective recovery strategy to prevent or alleviate post-COVID-19 conditions, although further research is needed to confirm long-term effectiveness and mechanisms of action. TRIAL REGISTRATION: The study was registered in the Chinese Clinical Trial Registry (#ChiCTR2100051901) from 2021-10-09.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。